UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 565

Sortiert nach

National Cancer Institute Formulary: A Public‐Private Partnership Providing Investigators Access to Investigational Anticancer Agents

Clinical pharmacology and therapeutics, 2017-05, Vol.101 (5), p.616-618

2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome

Annals of oncology, 2008-11, Vol.19 (11), p.1853-1859

2008

Link zum Volltext

Verfügbarkeit prüfen

Expression, characterization, and tissue distribution of a new cellular selenium-dependent glutathione peroxidase, GSHPx-GI

The Journal of biological chemistry, 1993-02, Vol.268 (4), p.2571-2576

1993

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

Journal of clinical oncology, 1995-06, Vol.13 (6), p.1303-1311

1995

Link zum Volltext

Verfügbarkeit prüfen

CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute

Oncogene, 2012-01, Vol.31 (4), p.403-418

2012

Link zum Volltext

Verfügbarkeit prüfen

Merrill Jon Egorin, MD, 1948-2010

Clinical pharmacology and therapeutics, 2011-02, Vol.89 (2), p.163-165

2011

Link zum Volltext

Verfügbarkeit prüfen

The NADPH oxidase NOX5 protects against apoptosis in ALK-positive anaplastic large-cell lymphoma cell lines

Free radical biology & medicine, 2015-07, Vol.84, p.22-29

2015

Link zum Volltext

Verfügbarkeit prüfen

Role of Hydrogen Peroxide and Hydroxyl Radical Formation in the Killing of Ehrlich Tumor Cells by Anticancer Quinones

Proceedings of the National Academy of Sciences - PNAS, 1986-06, Vol.83 (12), p.4514-4518

Doroshow, James H.

1986

Link zum Volltext

Verfügbarkeit prüfen

Microflora trigger colitis in mice deficient in selenium-dependent glutathione peroxidase and induce Gpx2 gene expression

Biological chemistry, 2003-04, Vol.384 (4), p.597-607

2003

Link zum Volltext

Verfügbarkeit prüfen

Doxorubicin-Induced Cardiac Toxicity

The New England journal of medicine, 1991-03, Vol.324 (12), p.843-845

Doroshow, James H

1991

Link zum Volltext

Verfügbarkeit prüfen

Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase

The Journal of biological chemistry, 1986-03, Vol.261 (7), p.3060-3067

1986

Link zum Volltext

Verfügbarkeit prüfen

Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical

The Journal of biological chemistry, 1986-03, Vol.261 (7), p.3068-3074

1986

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of Adjuvant Human Interferon Gamma Versus Observation in High-Risk Cutaneous Melanoma: a Southwest Oncology Group Study

JNCI : Journal of the National Cancer Institute, 1995-11, Vol.87 (22), p.1710-1713

1995

Link zum Volltext

Verfügbarkeit prüfen

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

Blood, 2001-12, Vol.98 (12), p.3212-3220

2001

Link zum Volltext

Verfügbarkeit prüfen

Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer

British journal of cancer, 2002-07, Vol.87 (3), p.281-288

2002

Link zum Volltext

Verfügbarkeit prüfen

Utility of 18F-fluoroestradiol (18F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy

European journal of nuclear medicine and molecular imaging, 2017-03, Vol.44 (3), p.500-508

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support

Journal of clinical oncology, 1996-10, Vol.14 (10), p.2631-2637

1996

Link zum Volltext

Verfügbarkeit prüfen

High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival

Journal of clinical oncology, 1997-08, Vol.15 (8), p.2882-2893

1997

Link zum Volltext

Verfügbarkeit prüfen

Mice with combined disruption of Gpx1 and Gpx2 genes have colitis

American journal of physiology: Gastrointestinal and liver physiology, 2001-09, Vol.281 (3), p.G848-G855

2001

Link zum Volltext

Verfügbarkeit prüfen

High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome

British journal of cancer, 2001-06, Vol.84 (12), p.1591-1598

2001

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines

Journal of clinical oncology, 1989-04, Vol.7 (4), p.486-498

1989

Link zum Volltext

Verfügbarkeit prüfen

Glutathione peroxidase and oxidative stress

Toxicology letters, 1995-12, Vol.82, p.395-398

Doroshow, James H.

1995

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis

Cancer chemotherapy and pharmacology, 2000, Vol.46 (1), p.19-26

2000

Link zum Volltext

Verfügbarkeit prüfen

Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial

Annals of internal medicine, 1988-04, Vol.108 (4), p.518

1988

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 565

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(516)
Mit Volltextzugriff
(496)

Publikationsform

Sprache

Englisch
(565)
Japanisch
(46)

Erscheinungsjahr

n.n

Thema

Science & Technology
(298)
Life Sciences & Biomedicine
(291)
Humans
(288)
Oncology
(241)
Female
(173)
Biological And Medical Sciences
(165)
Medical Sciences
(153)
Middle Aged
(153)
Male
(141)
Adult
(137)
Pharmacology. Drug Treatments
(128)
Aged
(125)
Antineoplastic Agents
(121)
Chemotherapy
(72)
Neoplasms - Drug Therapy
(66)
Animals
(61)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(59)
Tumors
(58)
Pharmacology & Pharmacy
(52)
Drug Administration Schedule
(47)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

National Cancer Institute Formulary: A Public‐Private Partnership Providing Investigators Access to Investigational Anticancer Agents

Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome

Expression, characterization, and tissue distribution of a new cellular selenium-dependent glutathione peroxidase, GSHPx-GI

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute

Merrill Jon Egorin, MD, 1948-2010

The NADPH oxidase NOX5 protects against apoptosis in ALK-positive anaplastic large-cell lymphoma cell lines

Role of Hydrogen Peroxide and Hydroxyl Radical Formation in the Killing of Ehrlich Tumor Cells by Anticancer Quinones

Microflora trigger colitis in mice deficient in selenium-dependent glutathione peroxidase and induce Gpx2 gene expression

Doxorubicin-Induced Cardiac Toxicity

Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase

Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical

Randomized Trial of Adjuvant Human Interferon Gamma Versus Observation in High-Risk Cutaneous Melanoma: a Southwest Oncology Group Study

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer

Utility of 18F-fluoroestradiol (18F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy

Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support

High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival

Mice with combined disruption of Gpx1 and Gpx2 genes have colitis

Recombinant Human Thrombopoietin in Combination With Granulocyte Colony-Stimulating Factor Enhances Mobilization of Peripheral Blood Progenitor Cells, Increases Peripheral Blood Platelet Concentration, and Accelerates Hematopoietic Recovery Following High-Dose Chemotherapy

High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome

Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines

Glutathione peroxidase and oxidative stress

Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis

Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial

Suchergebnisse filtern